Blueprint Medicines Corporation | Blueprint Medicines | Massachusetts | state | 2017 | $525,000 | | tax credit/rebate |
Merrimack Pharmaceuticals, Inc. | Merrimack Pharmaceuticals | Massachusetts | state | 2015 | $1,350,000 | | tax credit/rebate |
Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals | Massachusetts | state | 2015 | $1,800,000 | | tax credit/rebate |
Abiomed, Inc. | Johnson & Johnson | Massachusetts | state | 2018 | $750,000 | | tax credit/rebate |
Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals | Massachusetts | state | 2018 | $1,650,000 | | tax credit/rebate |
EMD Holding Corporation | Merck KGaA (EMD) | Massachusetts | state | 2018 | $1,350,000 | | tax credit/rebate |
Abiomed, Inc | Johnson & Johnson | Massachusetts | state | 2019 | $459,125 | | tax credit/rebate |
Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals | Massachusetts | state | 2019 | $2,250,000 | | tax credit/rebate |
EMD Holding Corporation | Merck KGaA (EMD) | Massachusetts | state | 2019 | $1,125,000 | | tax credit/rebate |
EMD Holding Corporation | Merck KGaA (EMD) | Massachusetts | state | 2020 | $1,350,000 | | tax credit/rebate |
Blueprint Medicines Corporation | Blueprint Medicines | Massachusetts | state | 2020 | $1,065,000 | | tax credit/rebate |
Ultragenyx Pharmaceutical | Ultragenyx Pharmaceutical | Massachusetts | state | 2020 | $780,952 | | tax credit/rebate |
Abiomed Inc. | Johnson & Johnson | Massachusetts | state | 2021 | $675,000 | | tax credit/rebate |
Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals | Massachusetts | state | 2021 | $1,950,000 | | tax credit/rebate |
EMD Holding Corporation | Merck KGaA (EMD) | Massachusetts | state | 2021 | $1,725,000 | | tax credit/rebate |
Novavax Inc. | Novavax Inc. | Maryland | state | 2007 | $200,000 | | grant/loan hybrid program |
MedImmune Inc. | AstraZeneca | Maryland | state | 2006 | $7,500,000 | | grant/loan hybrid program |
Emergent BioSolutions | Emergent BioSolutions | Maryland | local | 2009 | undisclosed | | grant |
Cambrex | Cambrex | Maryland | local | 2007 | undisclosed | | grant |
Cangene bioPharma, Inc. | Emergent BioSolutions | Maryland | local | 2009 | undisclosed | | enterprise zone |
MedImmune, Inc. | AstraZeneca | Maryland | local | | $500,000 | | grant/loan hybrid program |
MacroGenics, Inc. | MacroGenics | Maryland | local | | $50,000 | | grant/loan hybrid program |
Novavax | Novavax Inc. | Maryland | local | | $200,000 | | grant/loan hybrid program |
United Therapeutics Corporation & Subs. | United Therapeutics | Maryland | state | 2010 | $21,746 | | tax credit/rebate |
Emergent Biosolutions, Inc. & Subsidiaries | Emergent BioSolutions | Maryland | state | 2010 | $19,113 | | tax credit/rebate |
Otsuka America Inc. | Otsuka Pharmaceutical | Maryland | state | 2010 | $65,321 | | tax credit/rebate |
Sucampo Pharma Americas, Inc. | Mallinckrodt | Maryland | state | 2010 | $15,746 | | tax credit/rebate |
Medimmune, LLC | AstraZeneca | Maryland | state | 2010 | $698,034 | | tax credit/rebate |
Amgen, Inc. | Amgen | Maryland | state | 2010 | $36,741 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | Maryland | state | 2010 | $20,997 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | Maryland | state | 2010 | $10,666 | | tax credit/rebate |
Teva Biopharmaceuticals, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2010 | $42,015 | | tax credit/rebate |
Pfizer Inc. & Subsidiaries | Pfizer | Maryland | state | 2010 | $18,433 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | Maryland | state | 2011 | $27,537 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | Maryland | state | 2011 | $7,890 | | tax credit/rebate |
United Therapeutics Corporation and Subs. | United Therapeutics | Maryland | state | 2011 | $17,214 | | tax credit/rebate |
Otsuka America, Inc. | Otsuka Pharmaceutical | Maryland | state | 2011 | $60,998 | | tax credit/rebate |
Astellas US Holding, Inc. | Astellas Pharma | Maryland | state | 2011 | $15,463 | | tax credit/rebate |
TEVA Biopharmaceuticals, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2011 | $26,524 | | tax credit/rebate |
Sucampo Pharma Americas, Inc. | Mallinckrodt | Maryland | state | 2011 | $37,575 | | tax credit/rebate |
Medimmune, LLC | AstraZeneca | Maryland | state | 2011 | $462,285 | | tax credit/rebate |
Emergent Biosolutions Inc. & Subsidiaries | Emergent BioSolutions | Maryland | state | 2011 | $17,868 | | tax credit/rebate |
Amgen, Inc. | Amgen | Maryland | state | 2011 | $36,726 | | tax credit/rebate |
Pfizer Inc. & Subsidiaries | Pfizer | Maryland | state | 2011 | $49,888 | | tax credit/rebate |
MedImmune, Inc. | AstraZeneca | Maryland | state | 2004 | $26,775 | | training reimbursement |
Shire US Manufacturing, Inc. | Takeda Pharmaceutical | Maryland | state | 2004 | $26,595 | | training reimbursement |
Shire US Manufacturing, Inc. | Takeda Pharmaceutical | Maryland | state | 2008 | $24,791 | | training reimbursement |
Shire US Manufacturing Inc. | Takeda Pharmaceutical | Maryland | state | 2007 | $23,191 | | training reimbursement |
Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals | Maryland | state | 2007 | $15,373 | | training reimbursement |
Medimmune, Inc. | AstraZeneca | Maryland | state | 2007 | $1,570,977 | | tax credit/rebate |
Medimmune, LLC | AstraZeneca | Maryland | state | 2012 | $1,497,096 | | tax credit/rebate |
Medimmune, Inc. | AstraZeneca | Maryland | state | 2005 | $728,623 | | tax credit/rebate |
Medimmune, LLC | AstraZeneca | Maryland | state | 2008 | $611,575 | | tax credit/rebate |
Shire Holdings US, AG | Takeda Pharmaceutical | Maryland | state | 2004 | $588,423 | | tax credit/rebate |
Medimmune, LLC | AstraZeneca | Maryland | state | 2009 | $490,223 | | tax credit/rebate |
Medimmune, Inc. | AstraZeneca | Maryland | state | 2004 | $294,900 | | tax credit/rebate |
MacroGenics, Inc. and Subsidiaries | MacroGenics | Maryland | state | 2008 | $251,056 | | tax credit/rebate |
Otsuka America, Inc. | Otsuka Pharmaceutical | Maryland | state | 2005 | $195,386 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | Maryland | state | 2009 | $191,686 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | Maryland | state | 2008 | $131,514 | | tax credit/rebate |
Amgen, Inc. | Amgen | Maryland | state | 2008 | $126,743 | | tax credit/rebate |
Pfizer Corporation | Pfizer | Maryland | state | 2007 | $123,426 | | tax credit/rebate |
Medimmune Oncology, Inc. | AstraZeneca | Maryland | state | 2005 | $111,606 | | tax credit/rebate |
Amgen, Inc. | Amgen | Maryland | state | 2007 | $111,395 | | tax credit/rebate |
Medimmune Oncology, Inc. | AstraZeneca | Maryland | state | 2004 | $103,579 | | tax credit/rebate |
Emergent Biosolutions Inc. & Subsidiaries | Emergent BioSolutions | Maryland | state | 2012 | $103,503 | | tax credit/rebate |
United Therapeutics Corporation | United Therapeutics | Maryland | state | 2007 | $100,927 | | tax credit/rebate |
Otsuka America Pharmaceutical, Inc. | Otsuka Pharmaceutical | Maryland | state | 2008 | $96,916 | | tax credit/rebate |
MacroGenics, Inc. | MacroGenics | Maryland | state | 2007 | $94,861 | | tax credit/rebate |
Otsuka American Pharmaceutical, Inc. | Otsuka Pharmaceutical | Maryland | state | 2007 | $92,420 | | tax credit/rebate |
Amgen Inc. | Amgen | Maryland | state | 2004 | $88,478 | | tax credit/rebate |
MacroGenics, Inc. | MacroGenics | Maryland | state | 2012 | $80,651 | | tax credit/rebate |
Teva Biopharmaceuticals, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2008 | $76,270 | | tax credit/rebate |
Pharmacia Corporation | Pfizer | Maryland | state | 2008 | $74,621 | | tax credit/rebate |
Astellas US Holding, Inc. | Astellas Pharma | Maryland | state | 2012 | $74,558 | | tax credit/rebate |
Otsuka America, Inc. c/o Otsuka America Pharmaceutical, Inc. | Otsuka Pharmaceutical | Maryland | state | 2009 | $65,411 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | Maryland | state | 2008 | $64,386 | | tax credit/rebate |
Amgen Inc. | Amgen | Maryland | state | 2005 | $61,793 | | tax credit/rebate |
Pfizer Inc. & Subsidiaries | Pfizer | Maryland | state | 2012 | $60,651 | | tax credit/rebate |
Pfizer Inc. | Pfizer | Maryland | state | 2005 | $60,097 | | tax credit/rebate |
Otsuka America, Inc. | Otsuka Pharmaceutical | Maryland | state | 2012 | $59,756 | | tax credit/rebate |
Emergent Product Development Gaithersburg, Inc. (FKA Emergent InnunoSolutions, Inc.) | Emergent BioSolutions | Maryland | state | 2007 | $58,921 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | Maryland | state | 2009 | $56,291 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | Maryland | state | 2008 | $56,054 | | tax credit/rebate |
Shire Holdings US, AG | Takeda Pharmaceutical | Maryland | state | 2005 | $53,032 | | tax credit/rebate |
Amgen, Inc. | Amgen | Maryland | state | 2012 | $50,617 | | tax credit/rebate |
Teva Biopharmaceuticals, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2012 | $50,570 | | tax credit/rebate |
Sucampo Pharmaceuticals, Inc. | Mallinckrodt | Maryland | state | 2004 | $50,128 | | tax credit/rebate |
Otsuka America, Inc. | Otsuka Pharmaceutical | Maryland | state | 2004 | $47,393 | | tax credit/rebate |
United Therapeutics Corporation & Subs. | United Therapeutics | Maryland | state | 2012 | $42,268 | | tax credit/rebate |
TEVA Biopharmaceuticals, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2009 | $41,319 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | Maryland | state | 2009 | $39,846 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | Maryland | state | 2012 | $39,722 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | Maryland | state | 2005 | $38,780 | | tax credit/rebate |
Amgen, Inc. | Amgen | Maryland | state | 2009 | $38,772 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | Maryland | state | 2007 | $37,440 | | tax credit/rebate |
Medimmune Oncology, Inc. | AstraZeneca | Maryland | state | 2007 | $36,938 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | Maryland | state | 2004 | $34,995 | | tax credit/rebate |
Emergent Product Development Gaithersburg, Inc. | Emergent BioSolutions | Maryland | state | 2005 | $34,357 | | tax credit/rebate |
Macrogenics, Inc. | MacroGenics | Maryland | state | 2005 | $34,280 | | tax credit/rebate |
Pfizer Inc. | Pfizer | Maryland | state | 2004 | $33,734 | | tax credit/rebate |